Carbamic Acid

Carbamic Acid

SCHEMBL4456965

C=O.NC(=O)O.NC(=O)O.NC(=O)O.NC(=O)O.NC(=O)O.NC(=O)O

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.78
LMNA P02545 6/20 0.50
ALDH1A1 P00352 4/20 0.50
TDP1 Q9NUW8 4/20 0.50
OR51E2 Q9H255 2/20 0.50
LDHA P00338 2/20 0.50
LDHB P07195 1/20 0.50
TSHR P16473 4/20 0.43
FGFR4 P22455 1/20 0.43
BLM P54132 5/20 0.42
PMP22 Q01453 4/20 0.42
ALOX15 P16050 2/20 0.42
CA2 P00918 2/20 0.40
CA9 Q16790 2/20 0.40
CA1 P00915 1/20 0.40
CYP3A4 P08684 4/20 0.36
HSD17B10 Q99714 3/20 0.36
NFKB1 P19838 2/20 0.36
HPGD P15428 2/20 0.36
CYP1A2 P05177 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carbamic Acid SCHEMBL4455938 1.00 ACHE (0.78) ACHELMNAALDH1A1TDP1OR51E2
Carbamic Acid SCHEMBL27532710 1.00
Carbamic Acid SCHEMBL3649121 1.00
Carbamic Acid SCHEMBL16295670 1.00 ACHE (0.78) ACHELMNAALDH1A1TDP1OR51E2
Carbamic Acid SCHEMBL4471040 1.00 ACHE (0.78) ACHELMNAALDH1A1TDP1OR51E2
Carbamic Acid SCHEMBL7526866 0.95 ACHE (0.70) ACHELMNAALDH1A1TDP1OR51E2
Carbamic Acid SCHEMBL2472526 0.89
Carbamic Acid SCHEMBL8987188 0.89 ACHE (0.78) ACHELMNAALDH1A1TDP1OR51E2
Carbamic Acid SCHEMBL8512703 0.88 ACHE (1.00) ACHELMNAALDH1A1TDP1OR51E2
Carbamic Acid SCHEMBL75781 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090149608-A1 Polycarbamides, polycarbamates, and polycarbamide-formaldehyde and polycarbamate-formaldehyde condensation resins MISSISSIPPI STATE UNIVERSITY 2009-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149608-A1 Polycarbamides, polycarbamates, and polycarbamide-formaldehyde and polycarbamate-formaldehyde condensation resins SUV39H1, PFAS, SUV39H2 ACHE 2967/4885LMNA 953/4885ALDH1A1 2009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.